Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$1.31 - $1.87 $140,694 - $200,838
-107,400 Reduced 50.64%
104,700 $139,000
Q2 2021

Aug 16, 2021

BUY
$1.86 - $6.22 $358,980 - $1.2 Million
193,000 Added 1010.47%
212,100 $405,000
Q1 2021

May 18, 2021

BUY
$3.58 - $6.45 $68,378 - $123,195
19,100 New
19,100 $85,000

Others Institutions Holding PLX

About Protalix BioTherapeutics, Inc.


  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $89.6M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.